LEDERMAN SETH (Chief Executive Officer) purchased 1500000.0% of their position (15K shares) of TONIX PHARMACEUTICALS HOLDING CORP. on the open market
Open‑market purchase worth $223.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/18/2026ACC: 0001999371-26-006235
DirectorOfficer· Chief Executive Officer
Since Jun 2018
+15K
Net shares
Net buyer
$223.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
15K acquired
Non-Derivative Transactions1
Common Stock, $0.001 par value
Indirect
Shares
+15K
Price / share
$14.89
Trade value
$223.35K
% of position
1500000.0%
3/18/2026
1.00→15K
Total
Net shares
+15K
Net value
$223.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Indirect | 3/18/2026 | P · Purchase | +15K | $14.89 | $223.35K | 1500000.0% | 1.00 | 15K |
| Total | +15K | $223.35K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock, $0.001 par value
IndirectShares owned1.00
Common Stock, $0.001 par value
DirectShares owned4K
Total
4K direct·1.00 indirect4.01K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 1.00 | Indirect |
| Common Stock, $0.001 par value | 4K | Direct |
| Total | 4.01K | 4K direct·1.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported